Mass. pharmacy recalling some compounded products

by Bob Salsberg

(AP)—A Massachusetts pharmacy has issued a voluntary recall of some sterile compounding products.

Pallimed Solutions Inc., of Woburn, said Monday the recall was a precautionary measure and there were no reports of any illnesses. It says it issued the recall after a recent unannounced inspection by state and federal regulators.

A person familiar with the investigation told The Associated Press that officials are analyzing a foreign substance that was visible in several vials. The person spoke on condition of because the investigation is ongoing.

The company says the recalled products were prepared for fewer than 800 patients and the recall doesn't involve any other product.

The state stepped up inspections of compounding pharmacies after a deadly fungal was linked to a steroid produced at a different pharmacy.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US pharmacy linked to outbreak issues wide recall

Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

FDA: Georgia pharmacy recalling all sterile drugs

Mar 21, 2013

(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.

US warns of mold in recalled specialty drugs

Mar 18, 2013

The U.S. Food and Drug Administration warned doctors and hospital managers Monday about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.

FDA: Ameridose issues voluntary recall of all products

Nov 02, 2012

(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

16 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments